Answers are grounded in this paper and cite their sources.
). Consequently, compound 11 holds promise as a lead molecule for developing novel therapeutic agents targeting α-amylase, α-glucosidase, and aldose reductase for diabetes management. Furthermore, molecular docking and molecular dynamics simulations (100 ns) elucidated stable interactions between compound 11 and the catalytic pockets of both α-amylase and α-glucosidase, primarily mediated by hydrogen bonding and hydrophobic interactions. The ADME analysis revealed an acceptable physicochemical profile, characterized by good aqueous solubility and a minimal predicted risk of CYP-mediated drug-drug interaction. Finally, these findings indicate that benzotriazole derivative 11 may serve as a promising scaffold for further optimization toward a multi-target anti-diabetic drug development agent.
No takes yet. Share an insight, caveat, or question.
El-Naggar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: